Here are four things to know:
1. Based on an average daily trading volume, of 1.12 million shares, the short-interest ratio is currently 2.5 days.
2. The company’s stock has a 50-day moving average price of $42.96 and a 200-day moving average price of $48.79.
3. NuVasive has a one-year low of $36.81 and a one-year high of $56.61.
4. The stock has a market cap of $2.32 billion.
More articles on devices:
ArthroMeda raises nearly $2M for hip replacement sensors — 5 takeaways
Mesoblast’s Mesenchymal Precursor Cells receives key patent — 5 takeaways
DJO Global 2015 net sales hit $308M; Net loss hits $349.9M: 8 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
